187
Views
5
CrossRef citations to date
0
Altmetric
Research Article

3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one and pregabalin attenuate tactile allodynia in the mouse model of chronic constriction injury

, , , , , , & show all
Pages 514-523 | Received 18 Jan 2015, Accepted 23 Mar 2015, Published online: 21 May 2015

References

  • Backonja MM. (2003). Defining neuropathic pain. Anesth Analg 97:785–90
  • Bannwarth B, Kostine M. (2014). Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists? Drugs 7:619–26
  • Becker A, Geisslinger G, Murín R, et al. (2013). Cannabinoid mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol 386:369–82
  • Bennett GJ, Xie YK. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87–107
  • Dymecki J, Kulczycki J. (2005). Neuropathology. Wroclaw: Urban & Partner
  • Fallon MT. (2013). Neuropathic pain in cancer. Br J Anaesth 111:105–11
  • Finnerup NB, Attal N, Haroutounian S, et al. (2015). Pharmacotherapy for neuropathic pain in adults: a systematic review and meta analysis. Lancet Neurol 14:162–73
  • Gagnon B, Almahrezi A, Schreier G. (2003). Methadone in the treatment of neuropathic pain. Pain Res Manag 8:149–54
  • Galli SJ, Nakae S, Tsai M. (2005). Mast cells in the development of adaptive immune responses. Nat Immunol 6:135–42
  • Gilron I, Bailey JM, Tu D, et al. (2005). Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352:1324–34
  • Gustafsson H, Sandin J. (2009). Oral pregabalin reverses cold allodynia in two distinct models of peripheral neuropathic pain. Eur J Pharmacol 605:103–8
  • Higgins GA, Lau W, Dykstra C, et al. (2012). Characterisation of acute and chronic administration of pregabalin (Lyrica) on multiple endpoints in the rat spared nerve injury model. SNF meeting; 2012 Oct 13–17; New Orleans
  • Horigome K, Bullock ED, Johnson EM Jr. (1994). Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 269:2695–702
  • Indo Y, Tsuruta M, Hayashida Y, et al. (1996). Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 13:485–8
  • Kaygisiz B, Kilic FS, Senguleroglu N, et al. (2015). The antinociceptive effect and mechanisms of action of pregabalin in mice. Pharmacol Rep 67:129–33
  • Leon A, Buriani A, Dal TR, et al. (1994). Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 91:3739–43
  • Lewin GR, Ritter AM, Mendell LM. (1993). Nerve growth factor induced hyperalgesia in the neonatal and adult rat. J Neurosci 13:2136–48
  • Lim HS, Kim JM, Choi JG, et al. (2013). Intrathecal ketamine and pregabalin at sub-effective doses synergistically reduces neuropathic pain without motor dysfunction in mice. Biol Pharm Bull 36:125–30
  • Litchfield JT, Wilcoxon E. (1949). A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113
  • Ming-Tatt L, Khalivulla SI, Akhtar MN, et al. (2013). Antihyperalgesic effect of a benzilidine-cyclohexanone analogue on a mouse model of chronic constriction injury-induced neuropathic pain: participation of the κ-opioid receptor and KATP. Pharmacol Biochem Behav 114–115:58–63
  • O’Connor AB, Dworkin RH. (2009). Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 122:S22–32
  • Okazaki R, Namba H, Yoshida H, et al. (2013). Combined antiallodynic effect of Neurotropin® and pregabalin in rats with L5-spinal nerve ligation. Life Sci 92:259–65
  • Petty BG, Cornblath DR, Adornato BT, et al. (1994). The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 36:244–6
  • Raivich G, Hellweg R, Kreutzberg GW. (1991). NGF receptor mediated reduction in axonal NGF uptake and retrograde transport following sciatic nerve injury and during regeneration. Neuron 7:151–64
  • Ritner HL, Machelska H, Stein C. (2009). Immune system pain and analgesia. In: Basbaum AI, Bushnell M, eds. Science of pain. Oxford: Academic Press 407–27
  • Sałat K, Cios A, Wyska E, et al. (2014a). Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl phenyl)-piperazin-1-yl] dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice. Pharmacol Biochem Behav 122:173–81
  • Sałat K, Filipek B, Wieckowski K, Malawska B. (2009). Analgesic activity of 3-mono substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain. Pharmacol Rep 61:807–18
  • Sałat K, Gawlik K, Witalis J, et al. (2013). Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethylphenyl)piperazin-1-yl] dihydrofuran-2-one in mice. Naunyn Schmiedebergs Arch Pharmacol 386:493–505
  • Sałat K, Głuch-Lutwin M, Nawieśniak B, et al. (2014b). Influence of analgesic active 3-[4-(3trifluoromethyl phenyl)-piperazin-1-yl]-dihydrofuran-2-one on the antioxidant status, glucose utilization and lipid accumulation in some in vitro and ex vivo assays. Toxicol Mech Methods 24:204–11
  • Sałat K, Kowalczyk P, Gryzło B, et al. (2014c). New investigational drugs for the treatment of neuropathic pain. Expert Opin Investig Drugs 23:1093–104
  • Sałat K, Moniczewski A, Salat R, et al. (2012). Analgesic, anticonvulsant and antioxidant activities of 3-[4-(3 trifluoromethyl-phenyl)piperazin-1-yl]dihydrofuran-2-one dihydrochloride in mice. Pharmacol Biochem Behav 101:138–47
  • Sałat R, Sałat K. (2013). The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin induced diabetic neuropathy. Comput Methods Programs Biomed 111:330–7
  • Sałat R, Sałat K. (2015). Modeling analgesic drug interactions using support vector regression: a new approach to isobolographic analysis. J Pharmacol Toxicol Methods 71:95–102
  • Toth C. (2012). Drug safety evaluation of pregabalin. Expert Opin Drug Saf 11:487–502
  • Villarinho JG, Pinheiro Kde V, Pinheiro Fde V, et al. (2013). The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model. Prog Neuropsychopharmacol Biol Psychiatry 44:136–42
  • Więckowski K, Sałat K, Bytnar J, et al. (2012). Search for anticonvulsant and analgesic active derivatives of dihydrofuran-2(3H) one. Bioorg Med Chem 20:6533–44
  • Zhao X, Yu C, Wang C, et al. (2014). Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: involvement of serotonergic system. Neuropharmacology 85:131–41
  • Zuo Y, Perkins NM, Tracey DJ, Geczy CL. (2003). Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 105:467–79

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.